David A. Patterson Silver Wolf has over 15 years of experience providing clinical services in the substance use disorder treatment field. Patterson Silver Wolf investigates how empirically supported interventions are implemented in community-based services, specifically as it relates to therapist and organizational characteristics.
Patterson Silver Wolf is a faculty scholar in the Washington University Institute for Public Health, a faculty affiliate in the Center for Violence and Injury Prevention, and serves as training faculty for two NIH- funded (T32) training programs at the Brown School, including the Transdisciplinary Training in Addictions Research program of the National Institute on Drug Abuse.
Patterson Silver Wolf also studies factors that improve underrepresented minority college students’ academic success. He is specifically interested in American Indian/Alaska Native health and wellness, particularly issues related to college retention.
At the Brown School he teaches substance abuse courses, chairs the American Indian and Alaska Native concentration in the Master of Social Work program, and works closely with Kathryn M. Buder Center Scholars.
After a decade of suffering from a still-raging opioid epidemic an overreaction to the treatment of addiction—mobile treatment, treatment guided by real-time data, treatment that follows patients back to their community—is very much overdue, writes David Patterson Silver Wolf.
It is time to bring this kind of real-time outcome data to America’s addiction crisis and make it available to the public. It’s the only way of knowing if what we’re doing to address the problem is making a difference. Without it, we’re relying on little more than prolonged intuition, writes David Patterson Silver Wolf.
As long as a racially and culturally homogeneous group of health leaders and decision-makers come solely from ivory towers and governmental offices, and not from the communities in the greatest need, the most marginalized and underserved among us will continue to pay the highest price, writes David Patterson Silver Wolf
David A. Patterson Silver Wolf, of the Brown School, writes in an op-ed on the Stat website that blaming drug addicts won’t solve the opioid crisis or encourage people to get the treatment they need.
After a decade of suffering from a still-raging opioid epidemic, after a century in which our advances in the treatment of substance use disorder can be counted on one or two hands, an overreaction to the treatment of addiction—mobile treatment, treatment guided by real-time data, treatment that follows patients back to their community—is very much overdue.
It is time to bring this kind of real-time outcome data to America’s addiction crisis and make it available to the public. It’s the only way of knowing if what we’re doing to address the problem is making a difference.
Similar to treatment resistant depression, there is a subpopulation of those addicted to opioids who do not respond to standard opioid use disorder treatments. In a new paper, an addiction expert at the Brown School at Washington University in St. Louis suggests a new category for these types of patients: treatment resistant opioid use disorder.
We are now in a renaissance period where psychedelic drugs are being reestablished as a new approach to very important public health problems. With protocol-driven specific trials, they might become critical medications for a wide range of psychiatric disorders, such as depression, PTSD, anxiety, and addictions.
As long as a racially and culturally homogeneous group of health leaders and decision-makers come solely from ivory towers and governmental offices, and not from the communities in the greatest need, the most marginalized and underserved among us will continue to pay the highest price.
The Community Academic Partnership on Addiction Clinic, a partnership between the Brown School and Preferred Family Healthcare, was able to increase treatment completion rates by 11% over a six-month time period.
Recent and upcoming legal battles involving drug makers represent a major tipping point in America’s fight against the opioid crisis, says an addiction expert at Washington University in St. Louis.
Any “brilliant idea” that does not permanently fund prevention and treatment infrastructures at the level needed to persistently address the devastating consequences of addiction should not be consider novel or a step in the right direction.
I’m coming to believe that the business side of the opioid epidemic might be the most powerful reason why so many practicing physicians remain below deck.
Although medications to treat opioid use disorder are safe and effective, most people who could benefit from these treatments do not receive them, finds a new report from the National Academies of Sciences, Engineering, and Medicine. The Brown School’s David Patterson Silver Wolf was one of the authors of the report.
The Brown School has partnered with Preferred Family Healthcare in St. Louis to launch the Community Academic Partnership on Addiction (CAPA), a teaching, learning and research clinic aimed at addressing substance use disorder. The Brown School’s David Patterson Silver Wolf serves as CAPA’s chief research officer.
Rather than social work practice being based solely on a therapist’s intuition and assumptions, social workers should consider a system of evaluation and measurement based on hard data, suggests a professor of social work at Washington University in St. Louis.
A new suite of technology tools developed by David Patterson Silver Wolf, associate professor at the Brown School, aims to enable addiction and behavioral health professionals to monitor their own treatment services, as well as their patient’s recovery process, using data as their guide.
Nearly 30 percent of U.S. college students drop out in their first year, on average. One segment of a campus population shown to experience a particularly difficult time fitting in: underrepresented minority students. Now, a new intervention program being implemented through the Brown School at Washington University in St. Louis aims to help minority students feel that they belong on campus.
President Donald Trump’s Oct. 26 announcement that the opioid epidemic is a “public health emergency” rather than a “national emergency” goes against the understanding of most authorities, said an expert on substance use disorder treatment at Washington University in St. Louis.
President Donald Trump declaring the opioid epidemic a national emergency is an important statement and first step toward admitting a problem, said an expert on opioid addiction at Washington University in St. Louis, while warning that without science-informed solutions and plans of action, the epidemic will worsen.
Opioids, including heroin and prescription drugs, killed more than 33,000 people in 2015, more than any year on record, according to the CDC. President Trump’s proposed budget aims to address the crisis with a $500 million increase in prevention and treatment, but it isn’t enough to address the issue, says an expert on substance use disorder treatment.
Graphic cigarette labels could be effective at reducing smoking rates in American Indian/Alaska Natives communities, according to research from the Brown School.
The Brown School’s Center for Social Development has launched a new initiative aimed at examining how racism and inequality affect quality of life in the U.S. The Collaboration on Race, Inequality, and Social Mobility in America will examine the impact of inequality and structural racism on people of color.
